Micron to Support Legit.Health in Marketing Activities for the Japanese Market

Micron, Inc. (hereafter, “Micron”, head office: Tokyo) is pleased to announce that Micron will support Legit.Health (head office: Spain)’s marketing activities aimed at developing and expanding Legit.Health (an AI-driven image assessment tool for dermatology) in Japan.

Legit.Health is a company that develops medical AI software. Legit.Health is an AI-based diagnosis and measurement support neural network for dermatology, which can be easily connected and expanded from existing systems. In addition, it is also an automatic patient-report outcome measurement (PRO: Patient-reported outcome) tool that allows subjects to report automated measurements of photo data taken with their own smartphones. Legit.Health diagnoses and measures the severity of 232 skin conditions from photos taken with a smartphone. Atopic dermatitis, urticaria, psoriasis, hidradenitis suppurativa, and acne vulgaris can be precisely evaluated and scored (SCORAD, EASI, PASI, IHS4, etc.) without using special hardware for image capture. With the technology of Legit.Health, it is possible to input scoring automatically in a short time with little variation.

In addition, this product can be used not only for traditional clinical trials, but also for decentralized clinical trials (DCT) and real-world evidence (RWE), as skin photographs can be reported via the internet. This product has obtained CE marking and is in the process of FDA medical device certification application. Furthermore, it has already been verified and used in more than 6 countries.

If you are interested, please contact us below.


Micron to Support Legit.Health in Marketing Activities for the Japanese Market
~An AI-Driven Image Assessment Tool for Dermatology (Legit.Health)~


Please contact :
Micron, Inc. Sales and Marketing Department